Lâle White is a nationally recognized expert in the field of medical financial management and regulatory compliance, with over 25 years of experience in information systems development and medical billing. White lectures extensively on these topics and has consulted for major laboratories and laboratory associations throughout the United States.
White worked with the Health Care Finance Administration and the United States Office of the Inspector General to develop the first OIG Model Compliance Program. She was previously Vice President-Finance at Laboratory Corporation of America (NYSE: LH), one of the largest clinical reference laboratories in the United States, and its predecessor National Health Laboratories (NYSE: NHLI), where she led the software development of several accounts receivable, inventory, cost accounting, and financial management systems for the laboratory industry.
White has a Bachelor of Arts degree in finance and a Master of Business Administration degree from Florida International University. She is a member of the Board of Directors of Combimatrix, a molecular diagnostics company specializing in DNA-based testing services for pre- and postnatal developmental disorders.
Julie Scott Allen has over two decades of experience as a government relations professional, advocating at the federal and state level to address Medicare and Medicaid payment and coverage and health care reform. She represents the interests of independent clinical laboratories through the National Independent Laboratory Association (NILA), serving as their Washington Representative and advocating before Congress and such agencies as the Centers for Medicare and Medicaid Services (CMS) and the Food and Drug Administration (FDA).